Serum NGAL as a Predictor of Clinical and Endoscopic Activity of Inflammatory Bowel Disease
NCT05151458 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2021-12-14
Summary
Ulcerative colitis (UC) and Crohns disease (CD) represent the two major forms of inflammatory bowel disease (IBD), characterized by epithelial cell damage and prominent mucosal infiltration by inflammatory cells including granulocytes, macrophages, lymphocytes, and plasma cells.
Conditions
- Inflammatory Bowel Diseases
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-12-29
- Primary Completion
- 2022-11-29
- Completion
- 2022-11-30
More Related Trials
-
IDENTIFICATION OF PROGNOSTIC AND PREDICTIVE BIOMARKERS IN INFLAMMATORY BOWEL DISEASE
NCT03809728 ·Status: RECRUITING ·Phase: NA
-
Immune Regulation in Ulcerative Colitis or Crohn s Disease
NCT00001184 ·Status: RECRUITING
-
Biomarkers in Inflammatory Bowel Diseases
NCT02612103 ·Status: COMPLETED
-
Neutrophil to Lymphocyte Ratio in Inflammatory Bowel Disease
NCT04558658 ·Status: UNKNOWN
-
Hematological Indices and Fecal Calprotectin Predict Histological Remission in Ulcerative Colitis
NCT04818788 ·Status: UNKNOWN
-
Novel Biomarkers in Inflammatory Bowel Disease
NCT03833310 ·Status: COMPLETED
-
Receptor for Advanced Glycation End Products (RAGE) Polymorphisms In Inflammatory Bowel Disease
NCT04286659 ·Status: UNKNOWN
-
In Vivo Molecular Imaging Predicts Therapeutic Response in Ulcerative Colitis
NCT02852850 ·Status: UNKNOWN
-
Comparing the Accuracy of Different Ultrasound-based Scores to Assess Disease Severity in Patients with Inflammatory Bowel Disease
NCT06705972 ·Status: NOT_YET_RECRUITING
-
Predictors of Prognosis in IBD Patients
NCT05653011 ·Status: RECRUITING
-
A Prospective Longitudinal Study of Fecal Microbiome and Calprotectin to Predict Relapse in Patients With IBD
NCT04079335 ·Status: UNKNOWN
-
Value of Fecal Calprotectin
NCT00577928 ·Status: COMPLETED
-
Predicting Response to Iron Supplementation in Patients With Active Inflammatory Bowel Disease
NCT05456932 ·Status: UNKNOWN ·Phase: PHASE4
-
Multi-omics to Predict Responses to Biologics in IBD
NCT05542459 ·Status: UNKNOWN
-
Assessment of Nutritional Knowledge in Patients With Inflammatory Bowel Disease
NCT04882566 ·Status: UNKNOWN
-
Correlation of Fecal Calprotectin and Fecal Immunochemical Test in Determination of Endoscopic Activity in Inflammatory Bowel Disease Patients
NCT06623383 ·Status: COMPLETED
-
Impact of Obesity on Response to Therapy and Clinical Outcom in Patients With Inflammatory Bowel Disease
NCT07343726 ·Status: NOT_YET_RECRUITING
-
Research for the Precision Medicine in the Treatment of Inflammatory Bowel Disease
NCT07166588 ·Status: ENROLLING_BY_INVITATION
-
A Study to Evaluate Non-invasive Measurements of the Inflammatory Status in Patients with IBD
NCT06900738 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Role of Altered Intestinal Permeability and Lipopolysaccharide in Thrombotic Risk and Vascular Injury in IBD Patients
NCT06772350 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Diagnostic Value of Serum Oncostatin M and Galactin 3 as Biomarkers in Diagnosis of Ulcerative Colitis Disease
NCT06959654 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Research and Follow-up of the Determinants of the Progression and Complications of Inflammatory Bowel Diseases Treated or Not With Immunosuppressants.
NCT07172945 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Platelet Indices in Inflammatory Bowel Diseases
NCT07320443 ·Status: NOT_YET_RECRUITING
-
Study of Inflammatory Markers (VNN1) in Crohn Disease and Ulcerative Colitis.
NCT02304666 ·Status: UNKNOWN ·Phase: NA
-
The Diagnostic Methods of Early Postoperative Flare-up of Crohn's Disease
NCT02578576 ·Status: UNKNOWN